DNA Script inks distribution agreement with Imperial Life Sciences, expands access to on-demand DNA synthesis in India: Our Bureau, Mumbai Tuesday, July 21, 2026, 12:00 Hrs [IST] ...
Karnataka government has strengthened measures to prevent and control viral fever and other communicable diseases by intensifying surveillance, enhancing healthcare preparedness, and promoting public ...
Our Bureau, Mumbai Tuesday, July 21, 2026, 11:30 Hrs [IST] Emcure Pharmaceuticals Limited announced that Poviztra, its co-marketed ...
Armata Pharma achieves key progress across clinical, regulatory and manufacturing activities supporting planned phase 3 initiation of AP-SA02: Los Angeles Tuesday, July 21, 2026, ...
WHO Member States have advanced negotiations on the Pathogen Access and Benefit Sharing (PABS) annex, a central component of the WHO Pandemic Agreement, while agreeing that continued discussions are ...
GSK announces EMA accepts submission to update Bexsero label for 1-dose Meningitis B booster in 10+ year olds: London, UK Tuesday, July 21, 2026, 09:00 Hrs [IST] GSK plc, a global ...
Haryana FDA detects spurious batches of Glenmark's Telma-AM tablets: Peethaambaran Kunnathoor, Chennai Tuesday, July 21, 2026, 08:00 Hrs [IST] In a major enforcement operation aim ...
Indian healthcare sector invests in modern training to enhance care quality & workforce retention: Nandita Vijayasimha, Bengaluru Tuesday, July 21, 2026, 08:00 Hrs [IST] The healt ...
Indian healthcare drives connected care emerging as the next big growth opportunity: Nandita Vijayasimha, Bengaluru Tuesday, July 21, 2026, 08:00 Hrs [IST] India's next healthcare ...
A Subject Expert Committee (SEC), which advises the central drug regulator in clinical trials and approval of new drugs, has recommended grant of approval for breast cancer drug Enhertu for two ...
Gireesh Babu, New Delhi Tuesday, July 21, 2026, 08:00 Hrs [IST] Exports of drugs and pharmaceuticals from the country have re ...
Halozyme enters global collaboration and license pact with Incyte to support the development of subcutaneous formulations of INCA033989 using its Enhanze technology: San Diego Tue ...